FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 124 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $18,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eventide Asset Management | 1,085,200 | $44,873,000 | 2.75% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 328,329 | $13,576,000 | 0.94% |
HAYS ADVISORY LLC | 135,722 | $5,612,000 | 0.87% |
AWM Investment Company, Inc. | 90,000 | $3,721,000 | 0.80% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 448,000 | $18,525,000 | 0.73% |
SPHERA FUNDS MANAGEMENT LTD. | 60,000 | $2,481,000 | 0.64% |
RTW INVESTMENTS, LP | 44,701 | $1,848,000 | 0.63% |
Telemetry Investments, L.L.C. | 26,000 | $1,075,000 | 0.58% |
Spark Investment Management LLC | 148,100 | $6,123,000 | 0.57% |
Perceptive Advisors | 169,439 | $7,006,000 | 0.49% |